HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A new stone occlusion device for upper ureteral calculi: preliminary clinical outcomes.

AbstractAIM:
To evaluate the efficacy and safety of the newly developed stone occlusion device in preventing retropulsion of upper ureteral calculi during laser lithotripsy.
METHODS:
A prospective randomized trial of 59 patients with upper ureteral calculi was conducted. Group I consisted of 27 patients using the new device. Group II consisted of 32 patients using the NTrap, a well studied and extensively used occluder. All patients underwent ureteroscopic Ho:YAG laser lithotripsy and operational parameters were compared in-between.
RESULTS:
Neither group had any obvious complications. There were no differences in operation time (p = 0.6881), intraoperative success rate (100%, respectively), postoperative stone-free rate (p = 1.000), or overall success rate (p = 1.000) between the two groups.
CONCLUSION:
This new device is clinically parallel to the effectiveness and safety of NTrap but is available at half the price and is clinically valid for extensive use. However, more investigations are warranted to confirm the efficacy and to contribute to device modification.
AuthorsChen-Chen Feng, Zhong Wu, Hao-Wen Jiang, Qiang Ding
JournalMinimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy (Minim Invasive Ther Allied Technol) Vol. 21 Issue 5 Pg. 351-4 (Sep 2012) ISSN: 1365-2931 [Electronic] England
PMID22575031 (Publication Type: Journal Article, Randomized Controlled Trial)
Topics
  • Adult
  • Aged
  • Female
  • Humans
  • Lithotripsy, Laser (methods)
  • Male
  • Middle Aged
  • Statistics as Topic
  • Time Factors
  • Treatment Outcome
  • Ureter (pathology)
  • Ureteral Calculi (therapy)
  • Ureteroscopy (methods)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: